Long term outcome after combined modality treatment for anal cancer
Open Access
|Apr 2012References
- Rousseau DL, Thomas CR, Petrelli NJ, Kahlenberg MS. Sqamous cell carcinoma of the anal canal.2005;: 121-32.
- But-Hadzic J, Jenko K, Poljak M, Kocjan BJ, Gale N, Strojan P. Sinonasal inverted papilloma associated with squamous cell carcinoma.2011;: 267-72.
- Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P. Prognostic value of tumour regression evaluated after first course of radiotherapy for anal canal cancer.2005;: 1316-24.
- Cancer incidence in Slovenia 2003. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2006.
- Cancer incidence in Slovenia 2004. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2007.
- Cancer incidence in Slovenia 2005. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2008.
- Cancer incidence in Slovenia 2006. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
- Cancer incidence in Slovenia 2007. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2010.
- Nigro ND, Vaitkevicius VK, Considine D. Combined therapy for cancer of the anal canal.1974;: 763-6.
- Fraunholz I, Rebeneck D, Weiß C, Rödel C. Combined-modality treatment for anal cancer.2010;: 361-6.
- Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: Retrospective analysis of the results and radiation dose effectiveness.2005;: 1136-42.
- Oblak I, Petric P, Anderluh F, Velenik V, Hudej R, Fras AP. Anal cancer chemoirradiation with curative intent - a single institution experience.2009;: 150-5.
- Sobin LH, Gospodarowitcz MK, Wittekind C. International Union Against Cancer (UICC): TNM classification of malignant tumours. 7th edition. New York: Wiley-Liss; 2009.
- Strojan P. Role of radiotherapy in melanoma management.2010;: 1-12.
- Ajani JA, Welch SR, Raber MN, Fiels WS, Krakoff IM. Comprehensive criteria for assessing therapy-induced toxicity.1990;: 147-59.
- LENT-SOMA scales for all anatomic sites.1995;: 1049-91.
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.1958;: 457-81.
- Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.1977;: 1-39.
- Cox DR. Regression models and life-tables.1972;: 187-220.
- Gerard JP, Ayzac L, Hun D, Romestaing P, Coquard R, Ardiet JM, et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.1998;: 249-56.
- Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with florouracil and radiotherapy, and a salvage chemoradiotherapy in the definitive nonsurgical treatment of the epidermoid carcinoma of the anal canal: results of a phase III randomozed intergroup study.1996;: 2527-39.
- Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.2008;: 1914-21.
- Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal. Prognostic factors of tumoural control and complications.1997;: 313-24.
- Akbari RP, Paty PB, Guillem JG, Weiser MR, Temple LK, Minsky BD, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.2004;: 1136-44.
- Cummings BJ, Brierley JD. Anal Cancer. In: Halperin EC, Perez CA, Brady LW, editors.5th edition. Philadelphia: Lippincott Williams & Wilkins, 2008. p. 1383-96.
- Schiller DE, Cummings BJ, Rai S, Le LW, Last L, Davey P, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.2007;: 2780-9.
- Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy.1998;: 1488-93.
- Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy.2003;: 452-8.
- Horsman MR, Van der Kogel A. Therapeutic approaches to tumour hypoxia. In: Joiner M, Van der Kogel A, editors.4th edition. London: Hodder Arnold, 2009. p. 233-45.
- Sato H, Koh PK, Bartolo DCC. Management of anal canal cancer.2005;: 1301-15.
- Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.1991;: 1115-25.
- Marshall DT, Thomas CR. Carcinoma of the anal canal.2009;: 27-40.
- Mitchell SE, Mendenhal WM, Zlotecki RA, Carroll RR. Squamous cell carcinoma of the anal canal.2001;: 1007-13.
- Hwang JM, Rao AR, Cosmatos HA, Wang R, Kaptein JS, Kagan RA, et al. Treatment of T3 and T4 anal carcinoma with combined chemotharapy and interstitial 192-Ir implantation: a 10-year experience.2004;: 95-100.
- Bailey DW, Kumaraswamy L, Podgorsak MB. A fully electronic intensitymodulated radiation therapy quality assurance (IMRT QA) process implemented in a network comprised of independent treatment planning, record and verify, and delivery systems.2010;: 124-30.
Language: English
Page range: 145 - 152
Published on: Apr 11, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2012 Irena Oblak, Primoz Petric, Franc Anderluh, Vaneja Velenik, Peter Fras, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.